ETX.L - e-Therapeutics plc
LSE - LSE Delayed price. Currency in GBp
7.375
-0.125 (-1.67%)
At close: 4:30PM BST
Stock chart is not supported by your current browser
| Previous close | 7.500 |
| Open | 7.250 |
| Bid | 0.000 x 0 |
| Ask | 0.000 x 0 |
| Day's range | 7.000 - 7.250 |
| 52-week range | 6.000 - 13.250 |
| Volume | 45,240 |
| Avg. volume | 29,085 |
| Market cap | 19.804M |
| Beta | -0.10 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.000 |
| Earnings date | 21 Sep 2017 - 22 Sep 2017 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.00 |
- Business Wire•2 months ago
e-therapeutics plc: Full Year Results
e-therapeutics plc , the drug discovery company, announces its full year results for the year ended 31 January 2018.
- Business Wire•2 months ago
e-therapeutics plc: Full Year Results
OXFORD, England--(BUSINESSWIRE)-- e-therapeutics plc (AIM: ETX, “e-therapeutics” or the “Company”), the drug discovery company, announces its full year results for the year ended 31 January 2018. Highlights ...
- EQS Group•8 months ago
Edison issues update on e-Therapeutics (ETX)
Edison Investment Research Limited05-Oct-2017 / 11:34 GMT/BST
- EQS Group•8 months ago
Edison Investment Research Limited: Edison issues outlook on Regional REIT (RGL)
Edison Investment Research Limited04-Oct-2017 / 12:34 GMT/BST
- EQS Group•8 months ago
Edison Investment Research Limited: Edison issues outlook on Carclo (CAR)
Edison Investment Research Limited03-Oct-2017 / 09:40 GMT/BST
- Business Wire•10 months ago
e-Therapeutics Announces Outcome of Strategic Review and Future Plans
OXFORD, England--(BUSINESSWIRE)-- E-THERAPEUTICS PLC (“e-Therapeutics” or the “Company”) e-Therapeutics plc (AIM: ETX): Upon the completion of Ray Barlow’s first three months as CEO of e-Therapeutics, ...